back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-06-09 18:35 Tx date 2026-06-05 |
$XENE
Xenon Pharmaceuticals Inc. |
Patou, Gary
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-70,251.08
-1,322 vol $53.14 each |
29,787 | |
| Filed 2026-06-05 17:33 Tx date 2026-06-03 |
$XENE
Xenon Pharmaceuticals Inc. |
Patou, Gary
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,593 vol |
1,593 | |
| Filed 2026-06-05 17:33 Tx date 2026-06-03 |
$XENE
Xenon Pharmaceuticals Inc. |
Patou, Gary
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,507 vol |
133,036 | |
| Filed 2026-06-05 17:30 Tx date 2026-06-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Patou, Gary
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+2,645 vol |
31,109 | |
| Filed 2026-06-05 17:25 Tx date 2026-06-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Patou, Gary
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-2,645 vol |
0 | |
| Filed 2025-06-10 12:52 Tx date 2025-06-05 |
$XENE
Xenon Pharmaceuticals Inc. |
Patou, Gary
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
50 - Grant of options
|
+2,645 vol |
2,645 | |
| Filed 2025-06-10 12:51 Tx date 2014-11-05 |
$XENE
Xenon Pharmaceuticals Inc. |
Patou, Gary
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-06-10 12:50 Tx date 2025-06-05 |
$XENE
Xenon Pharmaceuticals Inc. |
Patou, Gary
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+17,012 vol |
122,529 | |
| Filed 2024-12-18 19:45 Tx date 2024-11-22 |
$XENE
Xenon Pharmaceuticals Inc. |
Patou, Gary
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
+4,891 vol |
28,464 | |
| Filed 2024-12-18 19:41 Tx date 2024-11-22 |
$XENE
Xenon Pharmaceuticals Inc. |
Patou, Gary
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-3,086 vol |
105,517 | |
| Filed 2024-12-18 19:39 Tx date 2024-11-22 |
$XENE
Xenon Pharmaceuticals Inc. |
Patou, Gary
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-3,500 vol |
108,603 | |
| Filed 2024-12-18 19:15 Tx date 2024-11-22 |
$XENE
Xenon Pharmaceuticals Inc. |
Patou, Gary
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-83,742
-2,040 vol $41.05 each |
23,573 | |
| Filed 2024-12-18 19:14 Tx date 2024-11-22 |
$XENE
Xenon Pharmaceuticals Inc. |
Patou, Gary
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-41,630.80
-1,046 vol $39.80 each |
25,613 | |
| Filed 2024-12-18 19:12 Tx date 2024-11-22 |
$XENE
Xenon Pharmaceuticals Inc. |
Patou, Gary
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$41,599
+3,086 vol $13.48 each |
26,659 | |
| Filed 2024-12-18 19:10 Tx date 2024-11-22 |
$XENE
Xenon Pharmaceuticals Inc. |
Patou, Gary
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-117,204.61
-2,851 vol $41.11 each |
23,573 | |
| Filed 2024-12-18 17:32 Tx date 2024-11-22 |
$XENE
Xenon Pharmaceuticals Inc. |
Patou, Gary
4 - Director of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-25,830.20
-649 vol $39.80 each |
26,424 | |
| Filed 2024-12-18 17:27 Tx date 2024-11-22 |
$XENE
Xenon Pharmaceuticals Inc. |
Patou, Gary
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$25,830
+3,500 vol $7.38 each |
27,073 | |
| Filed 2024-06-07 14:46 Tx date 2024-06-05 |
$XENE
Xenon Pharmaceuticals Inc. |
Patou, Gary
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$593,082
+15,542 vol $38.16 each |
112,103 | |
| Filed 2023-12-18 15:46 Tx date 2023-12-14 |
$XENE
Xenon Pharmaceuticals Inc. |
Patou, Gary
4 - Director of Issuer
Holder: Gary & Karen Barbara Patou TTEE Patou Family Trust FBO Gary Patou Karen Barbara Patou (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-311,897.90
-7,598 vol $41.05 each |
4,902 | |
| Filed 2023-12-18 15:41 Tx date 2023-12-13 |
$XENE
Xenon Pharmaceuticals Inc. |
Patou, Gary
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-158,443.68
-3,977 vol $39.84 each |
23,573 |